Pfizer

Yahoo Finance • 13 hours ago

Sector Update: Health Care Stocks Softer Late Afternoon

Health care stocks declined late Wednesday afternoon with the NYSE Health Care Index dropping 0.5% a PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 15 hours ago

Sector Update: Health Care Stocks Softer Wednesday Afternoon

Health care stocks declined Wednesday afternoon, with the NYSE Health Care Index and the State Stree PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 17 hours ago

Palantir outperforms bulk of enterprise software stocks during 2025

[Allen & Co Brings Together Media And Tech Titans In Sun Valley] Kevin Dietsch/Getty Images News Despite a banner year for a wide range of semiconductor companies in the tech sector, most enterprise software stocks demonstrated more muted... Full story

Yahoo Finance • 18 hours ago

Pfizer and GSK Lead 2026 U.S. Drug Price Hikes

This article first appeared on GuruFocus. Pfizer (NYSE:PFE) and GlaxoSmithKline (NYSE:GSK) are among the top drugmakers planning price increases for hundreds of branded medicines in the U.S. next year, according to a Tuesday report from 3... Full story

Yahoo Finance • 18 hours ago

Salesforce Stock Could Jump as AI Revenue Gains Momentum in 2026

This article first appeared on GuruFocus. Salesforce (NYSE:CRM) shares have lagged behind peers in recent years, raising questions about the company's AI strategy. Warning! GuruFocus has detected 5 Warning Signs with PFE. Is CRM fairly v... Full story

Yahoo Finance • 18 hours ago

Nvidia Seeks TSMC Talks as China Orders Outpace H200 GPU Supply

This article first appeared on GuruFocus. Nvidia (NASDAQ:NVDA) has held discussions with Taiwan Semiconductor (NYSE:TSM) about potentially increasing production of its H200 GPUs as demand from China accelerates, according to Reuters. Sour... Full story

Yahoo Finance • 21 hours ago

2 Unstoppable Dividend Stocks to Double Up on Right Now

Key Points Both companies have faced some headwinds recently, but the core businesses and dividend payouts remain strong. Blackstone is the top alternative asset manager in the world and operates as a premier global investment firm for in... Full story

Yahoo Finance • 22 hours ago

Market Chatter: Pfizer, GSK, Others to Raise US Prices on 350 Drugs in 2026

Pfizer (PFE), Sanofi (SNY), Novartis (NVS), and GSK (GSK) are among the drug makers planning price i PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • yesterday

Pfizer (PFE) Braces for Bumpy Years as Growth Pushed Out to 2029

Pfizer Inc. (NYSE:PFE) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026.Pfizer (PFE) Braces for Bumpy Years as Growth Pushed Out to 2029 On December 16, Pfizer Inc. (NYSE:PFE) said the next few years are expected to be... Full story

Yahoo Finance • 2 days ago

SA analyst upgrades/downgrades: PLTR, TGT, NET, PFE

[Emerging Financial Data - Stock Market, Prosperity, Bull Market - Blue Version] DKosig Recent analyst actions feature notable shifts in the technology and retail sectors, with Cloudflare (NET [https://seekingalpha.com/symbol/NET]) and Ta... Full story

Yahoo Finance • 2 days ago

Is Bristol Myers Squibb a Buy, Sell, or Hold in 2026?

Key Points Bristol Myers Squibb's financial results haven't been great in recent years. The giant drugmaker has been facing challenges, including several patent cliffs. New launches, pipeline progress, and a dividend program still make i... Full story

Yahoo Finance • 2 days ago

The past three years for Pfizer (NYSE:PFE) investors has not been profitable

In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market index fund. But in any portfolio, there are likely to be some stocks that fall short of that benchmark. We regret to repor... Full story

Yahoo Finance • 2 days ago

Want $300 in Super-Safe Dividend Income in 2026? Invest $2,670 Into the Following 3 Ultra-High-Yield Stocks.

Key Points Over the last half-century, dividend stocks have notably outperformed non-payers -- and have done so while being less volatile than the benchmark S&P 500. While some ultra-high-yielding income stocks are more trouble than they'... Full story

Yahoo Finance • 2 days ago

Here’s What Analysts Think About Pfizer Inc. (PFE)

Pfizer Inc. (NYSE:PFE) is one of the best affordable healthcare stocks to buy now. Scotiabank analyst Louise Chen reiterated a Buy rating on Pfizer Inc. (NYSE:PFE) on December 17 and set a price target of $30.00. The same day, Bernstein an... Full story

Yahoo Finance • 6 days ago

This Cancer-Fighting Biotech Surges Into Buy Zone As Earnings Soar 131%

Investors gave been rotating away from technology. This biotech stock has rallied into a buy zone amid sharp earnings growth. Continue Reading... Full story

Yahoo Finance • 6 days ago

Validea Detailed Fundamental Analysis - PFE

Below is Validea's guru fundamental report for PFIZER INC. (PFE). Of the 22 guru strategies we follow, PFE rates highest using our Earnings Yield Investor model based on the published strategy of Joel Greenblatt. This value model looks fo... Full story

Yahoo Finance • 6 days ago

Lilly and Novo Cut GLP-1 Prices as Pill Approvals Expand Access

This article first appeared on GuruFocus. Weight-loss drugs known as GLP-1s are increasingly reshaping healthcare and the pharmaceutical landscape, with Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO) emerging as the two dominant forces... Full story

Yahoo Finance • 8 days ago

PFE Factor-Based Stock Analysis

Below is Validea's guru fundamental report for PFIZER INC. (PFE). Of the 22 guru strategies we follow, PFE rates highest using our Earnings Yield Investor model based on the published strategy of Joel Greenblatt. This value model looks fo... Full story

Yahoo Finance • 9 days ago

Sector Update: Health Care Stocks Mixed Late Afternoon

Health care stocks were mixed late Tuesday afternoon, with the NYSE Health Care Index fractionally h PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 9 days ago

Pfizer reports patient death in hemophilia trial for Hympavzi

[Pfizer] no_limit_pictures Pfizer (PFE [https://seekingalpha.com/symbol/PFE]) on Tuesday announced that a patient who was taking part in a long-term extension trial for its hemophilia therapy Hympavzi (marstacimab) died after serious adve... Full story